# Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

> **NCT00796614** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 231 (actual)

## Conditions studied

- Bladder, Neurogenic

## Interventions

- **DRUG:** tamsulosin hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00796614
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2015-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796614, "Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00796614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*